Filter by

Beige - Journal of Hypertension 2017

Blood pressure after blinded, randomized withdrawal, and resumption of baroreceptor-activating therapy
Read the publication

DeLeeuw - Hypertension 2017

Sustained Reduction of Blood Pressure With Baroreceptor Activation Therapy - Results of the 6-Year Open Follow-Up
Read the publication

Edoardo Gronda - J Cardiovasc Med 2017,

Baroreflex activation therapy: a new approach to the management of advanced heart failure with reduced ejection fraction

Wachter JASH 2017

An exploratory propensity score matched comparison of second-generation and first-generation baroreflex activation therapy systems
Read the publication

Abraham WT et al. 2015

Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction.
Read the publication

Zile MR Eur J Heart Fail. 2015.

Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy
Read the publication

Gronda J Hypertens 2015

Long-term chronic baroreflex activation: persistent efficacy in patients with heart failure and reduced ejection fraction
Read the publication

Gronda - European Journal of Heart Failure 2014

Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study
Read the publication

Bakris_JASH 2012

Baroreflex Activation Therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial
Read the publication

Hoppe - JASH2012

Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial
Read the publication
top of page